Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholinesterase Inhibitors”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00191009
What this trial is testing

Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 124
Large-scale testing (Phase 3)Ended earlyNCT02004392
What this trial is testing

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 348
Not applicableStudy completedNCT00423228
What this trial is testing

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Who this might be right for
Moderate Alzheimer's Disease
Debiopharm International SA 228
Very early researchEnded earlyNCT02357225
What this trial is testing

A Pilot Study of Pyridostigmine in Pompe Disease

Who this might be right for
Pompe Disease
University of Florida 2
Not applicableUnknownNCT02305589
What this trial is testing

The Clinical Changes Before and After Sugammadex in the Patients Undergoing Hip Surgery on the Aspect of Delirium

Who this might be right for
Delirium
Konkuk University Medical Center 250
Not applicableStudy completedNCT00748007
What this trial is testing

Efficacy of Rivastigmine in Patients With Down Syndrome

Who this might be right for
Down Syndrome
National Taiwan University Hospital 14
Large-scale testing (Phase 3)Study completedNCT00151502
What this trial is testing

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Who this might be right for
Alzheimer's Disease
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Post-approval studies (Phase 4)Looking for participantsNCT07633470
What this trial is testing

Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Who this might be right for
Alzheimer Disease
Alpha Cognition, Inc 150
Very early researchStudy completedNCT03445104
What this trial is testing

Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise

Who this might be right for
Cognitive Enhancement During Exercise
St. Louis University 15
Not applicableStudy completedNCT00533065
What this trial is testing

Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone

Who this might be right for
Elderly
Ludwig Boltzmann Gesellschaft 80
Large-scale testing (Phase 3)UnknownNCT00866099
What this trial is testing

Dementia Early Recognition and Response in Primary Care

Who this might be right for
Dementia
University College, London 125
Post-approval studies (Phase 4)Study completedNCT00480870
What this trial is testing

The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients

Who this might be right for
Alzheimer DiseaseSleep Apnea, Obstructive
Associacao Fundo de Incentivo a Psicofarmcologia 65
Post-approval studies (Phase 4)Study completedNCT00551161
What this trial is testing

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Northwell Health 12
Testing effectiveness (Phase 2)Study completedNCT02258152
What this trial is testing

SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)

Who this might be right for
Parkinson's Disease Dementia (PDD)
Biotie Therapies Inc. 82
Post-approval studies (Phase 4)UnknownNCT00142324
What this trial is testing

CALM-AD

Who this might be right for
Alzheimer's Disease
Institute of Psychiatry, London 190
Post-approval studies (Phase 4)Study completedNCT00443014
What this trial is testing

The Dementia Study in Northern Norway

Who this might be right for
Alzheimer Disease
University Hospital of North Norway 187
Large-scale testing (Phase 3)Study completedNCT02248636
What this trial is testing

Cholinesterase Inhibitor Discontinuation

Who this might be right for
Dementia
VA Office of Research and Development 72
Large-scale testing (Phase 3)Study completedNCT04226248
What this trial is testing

CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)

Who this might be right for
Parkinson Disease
University of Bristol 600
Testing effectiveness (Phase 2)Study completedNCT00880412
What this trial is testing

Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Exonhit 197
Testing effectiveness (Phase 2)Ended earlyNCT01690195
What this trial is testing

Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 343
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation